Leukemia
📧 Sign up to get email alerts when something new happens for Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
Memorial Sloan Kettering Cancer Center is recruiting families for genetic studies of familial lymphoproliferative disorders, including lymph…
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: Luspatercept for the Treatment of Anemia Following Allogeneic Hematopoietic Stem Cell Transplantation(Allo-HSCT) [Phase 1, Phase 2]
This clinical trial update indicates that luspatercept is being studied in Phase 1/2 for treating anemia after allogeneic hematopoietic stem…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: A Study of Revumenib and Mezigdomide in People With Leukemia [Phase 1, Phase 2]
Clinical trial update describing a Phase 1/2 study of Revumenib and Mezigdomide for various forms of leukemia, currently recruiting.
-
CLINICAL_TRIALS research · 2026-01-16Clinical Trial Update: A Phase 1 Study of CG009301 for Injection in Adult Subjects With Recurrent or Refractory Haematological Malignancies [Phase 1]
A Phase 1 study evaluating CG009301 for injection in adults with recurrent or refractory hematologic malignancies; recruitment is ongoing fo…
-
CLINICAL_TRIALS trial_result · 2026-01-15Clinical Trial Update: Removing Transfusion Dependence as a Barrier to Hospice Enrollment [NA]
A completed clinical trial update indicates that transfusion dependence was removed as a barrier to hospice enrollment for patients with hem…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-01-09Clinical Trial Update: Tegavivint for the Treatment of Relapsed or Refractory Leukemia [Phase 1]
Phase 1 trial update for tegavivint in relapsed or refractory leukemia; the study is active but not recruiting.
-
CLINICAL_TRIALS research · 2026-01-09Clinical Trial Update: International Leukemia Target Board
This clinical trial update notes that the International Leukemia Target Board trial, sponsored by Princess Maxima Center for Pediatric Oncol…
-
CLINICAL_TRIALS trial_result · 2026-01-08Clinical Trial Update: Strength Training Exercises to Minimise Late Effects of Childhood Leukaemia or Lymphoma Among Adolescents [NA]
This completed clinical trial investigates strength training to minimize late effects in adolescents who survived childhood leukemia or lymp…
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: Factors Affecting Post-transplant Cyclophosphamide (PTCy) Efficacy
This clinical trial is recruiting to study factors that influence the effectiveness of post-transplant cyclophosphamide in leukemia patients…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: Palifermin With Leuprolide Acetate for the Promotion of Immune Recovery Following Total Body Irradiation Based T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation [Phase 2]
Phase 2 clinical trial evaluating palifermin in combination with leuprolide acetate to promote immune recovery after total body irradiation-…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: Polymer-lipid Particle-delivered CAR1920 mRNA CAR-T Therapy for Relapsed/Refractory B-cell Lymphoma/Leukemia [Phase 2]
Phase 2 clinical trial evaluating polymer-lipid particle-delivered CAR1920 mRNA CAR-T therapy for relapsed/refractory B-cell lymphoma and le…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: Ascertainment of Peripheral Blood or Saliva Samples for Genetic Epidemiology Studies of Familial Cancers
The document describes an ongoing clinical trial that collects peripheral blood or saliva samples for genetic epidemiology studies of famili…
-
CLINICAL_TRIALS withdrawal · 2026-01-06Clinical Trial Update: Immune Reconstitution Monitoring and Pneumococcal Vaccination in Patients Treated With CAR-T Cells [Phase 1, Phase 2]
A Phase 1/Phase 2 study evaluating immune reconstitution monitoring and pneumococcal vaccination in patients treated with CAR-T cells has be…
-
CLINICAL_TRIALS research · 2026-01-06Clinical Trial Update: Peer Support Group for Adolescent and Young Adult (AYA) Allogeneic Stem Cell Transplant Recipients [NA]
Completed study investigating a peer support group for adolescent and young adult allogeneic stem cell transplant recipients.
-
CLINICAL_TRIALS research · 2026-01-02Clinical Trial Update: Preemptive CIML NK Cell Therapy After Hematopoietic Stem Cell Transplantation [Phase 1]
Phase 1 clinical trial evaluating preemptive CIML NK cell therapy after hematopoietic stem cell transplantation in patients with acute myelo…
-
CLINICAL_TRIALS research · 2025-12-30Clinical Trial Update: A Clinical Study Evaluating the Safety and Efficacy of GT719 Universal Cell Injection in Adult Participants With Relapsed/Refractory CD19-positive B-cell Malignant Hematological Tumors [EARLY_Phase 1]
This document provides an update on an early-phase clinical trial evaluating the safety and efficacy of GT719 Universal Cell Injection in ad…
-
CLINICAL_TRIALS research · 2025-12-26Clinical Trial Update: Reduced-Dose Apixaban and Rivaroxaban Versus Low-Molecular-Weight Heparin in Patients With Hematologic Malignancies [NA]
This clinical trial compares reduced-dose apixaban and rivaroxaban against low-molecular-weight heparin for venous thromboembolism managemen…
-
CLINICAL_TRIALS research · 2025-12-26Clinical Trial Update: Randomised Controlled Trial of Artificial Intelligence-assisted Health Education [NA]
A randomized controlled trial to assess the effectiveness of artificial intelligence–assisted health education, sponsored by Zhongnan Hospit…
-
CLINICAL_TRIALS research · 2025-12-24Clinical Trial Update: Dose-Expansion Study of Low Dose Post-Transplant Cyclophosphamide/Tacrolimus/Ruxolitinib for Graft-versus-Host Disease (GVHD) Prophylaxis in Myeloablative Allogeneic Peripheral Blood Stem Cell Transplantation [Phase 2]
A Phase 2 dose-expansion study evaluating a low-dose post-transplant cyclophosphamide/tacrolimus/ruxolitinib regimen for graft-versus-host d…
-
CLINICAL_TRIALS trial_result · 2025-12-24Clinical Trial Update: A Study Testing an Improved Dose of UM171 to Help Make Cord Blood Transplants More Effective and Safe. [Phase 1, Phase 2]
A Phase 1/2 clinical trial is testing an improved dose of UM171 to enhance the effectiveness and safety of cord blood transplantation; recru…
-
CLINICAL_TRIALS trial_result · 2025-12-23Clinical Trial Update: Impact of Supportive Care on the Experience of Hospitalization of Patients Staying in the Protected Area of the Department of Blood Diseases [NA]
Completed clinical trial assessing the impact of supportive care on the hospitalization experience for patients with acute leukemia undergoi…
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: xDRIVE for Florida-based Cancer Patients [NA]
A Florida-based clinical trial for a cancer therapy named xDRIVE is currently recruiting, sponsored by First Ascent Biomedical Inc.
-
CLINICAL_TRIALS trial_result · 2025-12-22Clinical Trial Update: PTCy + Sirolimus/VIC-1911 as GVHD Prophylaxis in Myeloablative PBSC Transplantation [Phase 1, Phase 2]
Phase 1/2 trial evaluating GVHD prophylaxis with post-transplant cyclophosphamide plus sirolimus and VIC-1911 in myeloablative peripheral bl…
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: Phase 1 Study of Chemotherapy Plus HLA-mismatched GPBMC Infusion Bridging to Allo-HSCT for R/R Leukemia [Phase 1]
This is a Phase 1 clinical trial evaluating chemotherapy plus HLA-mismatched GPBMC infusion as a bridge to allogeneic hematopoietic stem cel…
-
CLINICAL_TRIALS research · 2025-12-19Clinical Trial Update: Tumors and Respiratory System Diseases Due to Air Pollution: New Biomarkers of Exposure and Effects
This clinical trial update describes a study investigating new biomarkers of exposure and effects from air pollution on tumors and respirato…